Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 2 5 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 2 5 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that provides caloric support and prevents ketosis by entering the glycolytic pathway. Sodium chloride 0.9% is an isotonic crystalloid that expands extracellular fluid volume by increasing intravascular osmotic pressure. The combination repletes both free water and sodium deficits.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion, administered at a rate determined by clinical condition; typical maintenance fluid rate for adults is 100-200 mL/hour (2.4-4.8 L/day) with dextrose 2.5% providing 25-50 g glucose daily.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Clinical Note
moderateMagnesium sulfate + Gatifloxacin
"The serum concentration of Gatifloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Rosoxacin
"The serum concentration of Rosoxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Levofloxacin
"The serum concentration of Levofloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateDextrose: 30-60 minutes (utilization half-life) for glucose; for IV fluids, distribution half-life is minutes. Sodium chloride: elimination half-life varies with volume status; typical serum sodium half-life ~1-2 hours for acute load.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Dextrose: primarily metabolized to CO2 and water; <5% excreted unchanged in urine. Sodium chloride: excreted renally with >90% of sodium and chloride ions eliminated via kidneys; negligible biliary/fecal elimination.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte
Magnesium sulfate + Trovafloxacin
"The serum concentration of Trovafloxacin can be decreased when it is combined with Magnesium sulfate."